Verified factor-similar pair

VIOO vs XJR

These two ETFs meet the same FF6 US comparison criteria: US-listed equity ETFs, the same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.

SMB
Similarity score
95
Near substitute

The score combines exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.

Quick Read

  • VIOO has the higher backtested relative Sharpe (1.191 vs 0.880).
  • VIOO has the lower published fee (0.07% vs 0.12%).
  • VIOO is cheaper on dividend valuation (100 vs 179, where 100 is each fund's historical median).

These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.

VIOO

Vanguard S&P Small-Cap 600 ETF
SMB
Adj. R2
0.979
Rel. Sharpe
1.191
Mkt beta
0.98
AUM
US$3.6B
MER
0.07%
Valuation
100

XJR

iShares ESG Select Screened S&P Small-Cap ETF
SMB
Adj. R2
0.976
Rel. Sharpe
0.880
Mkt beta
0.98
AUM
US$130M
MER
0.12%
Valuation
179

Factor Exposure Match

Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.

SMB
VIOO
+0.90
|t|
+34.2
XJR
+0.98
|t|
+21.8
diff -0.08
HML
VIOO
+0.22
|t|
+8.4
XJR
+0.18
|t|
+4.2
diff +0.04
RMW
VIOO
+0.13
|t|
+4.3
XJR
+0.17
|t|
+3.7
diff -0.04
CMA
VIOO
+0.02
|t|
+0.5
XJR
+0.01
|t|
+0.1
diff +0.01
UMD
VIOO
+0.07
|t|
+3.6
XJR
+0.07
|t|
+2.2
diff -0.00

Why This Pair Matches

Exposure level
95
Exposure shape
100
Mkt beta diff
0.00
Rel. Sharpe diff
0.310

This comparison focuses on measured factor exposure. It does not compare holdings methodology, turnover, tax handling, or issuer process. Backtested relative Sharpe is a secondary signal rather than a stand-alone forecast. See methodology.

VIOO fund page XJR fund page US ETF Leaders US Universe
Important context

VerifiedBeta publishes educational ETF research, not personalized investment advice, portfolio management, or security recommendations. Funds that screen well here can still be unsuitable for your objectives, taxes, liquidity needs, or constraints. Review fund documents, methodology assumptions, and your own circumstances before acting. See the full disclaimer.